When medication is appropriate, the discussion should include: The limited evidence for GLP-1 agonists specifically in BED FDA-approved alternatives, including lisdexamfetamine Realistic expectations about outcomes and timeline Potential side effects and monitoring requirements Cost considerations and insurance coverage The importance of combining medication with behavioral interventions Monitoring during treatment should be systematic and multifaceted
All are resolved and paid
Garrett Evensen, Edmund Pakhlevanyan, April E
Eight strategies to make weight-loss medications more effective 6,21,22,23 6,21,22,23 1
Sometimes body composition changes (losing fat while maintaining muscle) wont show as dramatic scale movement but still represent significant progress
The medication builds to this level of effect through the combination of dose escalation and steady-state accumulation